FOXE1 and thyroid cancer: Recently, we demonstrated that FOXE1 dosage alteration affects thyroid cancer histology, proliferation and differentiation in vivo [20], thus showing for the first time a cause–effect relationship between FOXE1 and thyroid cancer phenotype.